AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 276 filers reported holding AVANOS MED INC in Q1 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $890 | -20.9% | 44 | 0.0% | 0.00% | – |
Q2 2023 | $1,125 | +99.1% | 44 | +131.6% | 0.00% | – |
Q1 2023 | $565 | +9.9% | 19 | 0.0% | 0.00% | – |
Q4 2022 | $514 | -48.6% | 19 | -67.2% | 0.00% | – |
Q3 2022 | $1,000 | 0.0% | 58 | +45.0% | 0.00% | – |
Q2 2022 | $1,000 | -92.9% | 40 | -90.4% | 0.00% | – |
Q1 2022 | $14,000 | 0.0% | 415 | 0.0% | 0.00% | – |
Q4 2021 | $14,000 | +7.7% | 415 | 0.0% | 0.00% | – |
Q3 2021 | $13,000 | -7.1% | 415 | +5.3% | 0.00% | – |
Q2 2021 | $14,000 | -100.0% | 394 | -64.6% | 0.00% | – |
Q1 2021 | $48,638,000 | +270111.1% | 1,112 | +182.2% | 0.00% | – |
Q4 2020 | $18,000 | +28.6% | 394 | -3.7% | 0.00% | – |
Q3 2020 | $14,000 | +16.7% | 409 | +3.8% | 0.00% | – |
Q2 2020 | $12,000 | +20.0% | 394 | 0.0% | 0.00% | – |
Q1 2020 | $10,000 | -23.1% | 394 | 0.0% | 0.00% | – |
Q4 2019 | $13,000 | -68.3% | 394 | -64.4% | 0.00% | -100.0% |
Q3 2019 | $41,000 | -35.9% | 1,108 | -25.3% | 0.00% | -50.0% |
Q2 2019 | $64,000 | -23.8% | 1,483 | +21.4% | 0.00% | -50.0% |
Q3 2018 | $84,000 | – | 1,222 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Paradice Investment Management LLC | 2,272,758 | $45,955,167 | 3.94% |
RGM Capital, LLC | 2,951,691 | $59,683,192 | 2.73% |
Tributary Capital Management, LLC | 707,122 | $14,298,007 | 1.35% |
HEARTLAND ADVISORS INC | 573,095 | $12,775,623 | 0.72% |
WESTWOOD HOLDINGS GROUP INC | 2,109,273 | $42,650 | 0.40% |
Foundry Partners, LLC | 212,556 | $4,297,882 | 0.27% |
Keene & Associates, Inc. | 13,675 | $276,509 | 0.22% |
J. Goldman & Co LP | 231,132 | $4,673,489 | 0.16% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 307,778 | $6,223,271 | 0.15% |
Invenomic Capital Management LP | 155,936 | $3,153,026 | 0.13% |